Validation of the Single-item Sleep Quality Scale
Launched by SCHULTHESS KLINIK · Sep 24, 2024
Trial Information
Current as of July 01, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a tool called the Single-item Sleep Quality Scale (SQS), which helps patients assess how well they have been sleeping over the past week. The goal is to adapt this tool for German and Italian speakers and to see how effective it is for people with spine disorders, like back pain. The study will take place in two parts: first, researchers will translate the SQS into German and Italian, and then they will test how well it works for patients with back issues.
To join the trial, participants need to be at least 14 years old, able to speak either German or Italian, and have a diagnosed spine problem. They should also be mentally capable of understanding the study. However, individuals who are pregnant, receiving treatment for sleep issues, or using sleep tracking devices won't be eligible. Participants will help researchers understand sleep quality among people with back disorders, and their involvement will contribute to improving patient care in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • both male and female patients
- • German-speaking or Italian-speaking
- • diagnosis of spine pathology
- • age ≥ 14 years
- • cognitively intact (self-reported)
- Exclusion Criteria:
- • pregnancy (self-reported)
- • medical and/or pharmacological treatment for sleep disorders
- • melatonin intake
- • daily use of smart-watch or applications for automatic sleep detection
- • inability to give informed consent
About Schulthess Klinik
Schulthess Klinik is a renowned medical institution based in Zurich, Switzerland, specializing in orthopedic surgery and rehabilitation. With a commitment to advancing patient care through innovative research and clinical trials, the clinic is dedicated to enhancing treatment outcomes and improving quality of life for individuals with musculoskeletal conditions. Schulthess Klinik combines state-of-the-art technology with a multidisciplinary approach, fostering collaborations among healthcare professionals to ensure comprehensive care and support for patients. Its reputation for excellence in clinical research positions Schulthess Klinik as a leader in the field, contributing valuable insights to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Zürich, Zh, Switzerland
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported